Search

everythinglearnresearchcommunity

for

Search:↓

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Both steroid treatments effectively regrow hair in severe alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Adalimumab helped control a child's severe eye disease when other treatments failed.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

A rare case links early-onset alopecia universalis and nephrotic syndrome, suggesting genetic immune issues.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Early immunosuppressive therapy leads to favorable outcomes in Filipino lupus patients with myocarditis.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.